Imaging Immune Activation in COVID-19

Clinical trial NCT04815096 · RECRUITING

Trial details

NCT number: NCT04815096
Sponsor: CellSight Technologies, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Covid19 SARS-CoV Infection

Start date: 2021-04-15
Primary completion: 2027-10-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.